Meeting
2013 ASCO Quality Care Symposium
Evaluating adherence to off-label policy at an academic outpatient cancer center and assessing reimbursement of high-cost drugs.
Authors
Gayle C. Blouin
Department of Pharmacy, Massachusetts General Hospital, Boston, MA
Gayle C. Blouin, Christine Chio, E. Bridget Kim, David P. Ryan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Science of Quality
Track
Science of Quality,Health Reform: Implications for Costs and Quality ,Practice of Quality
Sub Track
Quality Improvement
Citation
J Clin Oncol 31, 2013 (suppl 31; abstr 61)
Abstract #
61
Poster Bd #
C18
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
A successful model of biosimilar adoption in a community oncology practice.
First Author: Lalan S. Wilfong
Poster
2019 ASCO Annual Meeting
Quantification of the financial burden of antineoplastic agent price increases.
First Author: Michail Alevizakos
Poster
2014 ASCO Annual Meeting
Comparative health care (HC) costs and quality of care in five cancer types by physician office (PO) and hospital outpatient (HOP) settings.
First Author: Maxine Fisher
Poster
2014 ASCO Annual Meeting
Estimation of drug cost avoidance (DCA) and pathology cost avoidance (PCA) through participation in NCIC clinical trials group (NCIC-CTG) phase III clinical trials in Canada.
First Author: Patricia A. Tang